Study Evaluating Safety, Tolerability, Pharmacokinetics and 5 HT1A Receptor Occupancy
Status:
Completed
Trial end date:
2008-06-01
Target enrollment:
Participant gender:
Summary
The study will include a preliminary pharmacokinetics (PK) / safety / tolerability evaluation
in healthy elderly subjects followed by the Receptor Occupancy (RO) evaluations in healthy
elderly subjects and in Alzheimer's Disease (AD) subjects.